Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Wulf

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
European Journal of Haematology|May 24, 2018
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisSharifah Shahnaz Syed Abd Kadir, Maximilian Christopeit, Gerald Wulf, et al.
Bone Marrow Transplantation|December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyKlaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
EMBO Molecular Medicine|October 21, 2015
The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantationAntje Isernhagen, Dörthe Malzahn, Elena Viktorova, et al.
Blood|June 10, 2010
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyWolfgang A Bethge, Thoralf Lange, Christoph Meisner, et al.
European Heart Journal|July 17, 2012
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblastsKatrin Streckfuss-Bömeke, Frieder Wolf, Azadeh Azizian, et al.
Transplantation and Cellular Therapy|September 14, 2023
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation AnalysisPatrick Derigs, Wolfgang A Bethge, Isabelle Krämer, et al.
Bone Marrow Transplantation|December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemiaKlaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
Haematologica|November 2, 2020
A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patientsMarita Ziepert, Stefano Lazzi, Raffaella Santi, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
European Journal of Haematology|May 24, 2018
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisSharifah Shahnaz Syed Abd Kadir, Maximilian Christopeit, Gerald Wulf, et al.
Bone Marrow Transplantation|December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyKlaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
EMBO Molecular Medicine|October 21, 2015
The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantationAntje Isernhagen, Dörthe Malzahn, Elena Viktorova, et al.
Blood|June 10, 2010
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyWolfgang A Bethge, Thoralf Lange, Christoph Meisner, et al.
European Heart Journal|July 17, 2012
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblastsKatrin Streckfuss-Bömeke, Frieder Wolf, Azadeh Azizian, et al.
Transplantation and Cellular Therapy|September 14, 2023
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation AnalysisPatrick Derigs, Wolfgang A Bethge, Isabelle Krämer, et al.
Bone Marrow Transplantation|December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemiaKlaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
Haematologica|November 2, 2020
A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patientsMarita Ziepert, Stefano Lazzi, Raffaella Santi, et al.
Pageof 14